Breast cancer (BCa) is the leading cause of cancer death in women worldwide. It is the main cause of cancer-related death in women in developing countries (where many have advanced disease at presentation), and it is the second-leading cause in women in developed countries. Breast cancer has one of the highest potential years of life lost: almost 137,000 years, reflecting the burden of BCa in younger women.
Community practice of screening may differ from the care provided within randomized clinical trials and is less often discussed in review articles. Reviews of breast cancer screening usually emphasize efficacy and results of randomized trials, particularly those involving screen-film mammography. Efficacy of a screening tool is measured in experimental studies under ideal circumstances. In contrast, effectiveness is defined as the extent to which a specific intervention “when deployed in the field in routine circumstances, does what it is intended to do for a specific population.”
The evaluation of screening modalities, especially in the community setting, is challenging for methodological, clinical, and ethical reasons. Randomized clinical trials are considered the gold standard for evaluating a new screening test. The long-term breast cancer mortality rate of women randomized to receive a new screening test is compared with that of women randomized to receive standard care. However, such trials are difficult to conduct. They require tens of thousands of women who need to be followed up for more than 15 years. Furthermore, because mammography screening has been shown to be effective in some trials, it would likely be even more difficult to demonstrate any additional efficacy of new tests. Finally, as treatment for breast cancer has improved over time, the impact of screening on breast cancer mortality may be increasingly difficult to establish. Because of these challenges, new screening tests are often first studied by establishing characteristics of the tests themselves, rather than by studying their effect on patient outcome such as breast cancer mortality. Important test characteristics include sensitivity, specificity, safety, cost, simplicity, and patient and clinician acceptability. It is important to determine the characteristics of a screening test in a community setting if the test is to be used in that setting. However, test characteristics of new modalities are usually evaluated among women for whom the rate of breast cancer is higher than average, such as women at increased risk of breast cancer or women in a diagnostic setting with breast symptoms or known breast abnormalities. The reported sensitivity and specificity of a test in these high-risk women may be different from the sensitivity and specificity of the same test used in a general screening population.
Women aged 50 to 54 years should get mammograms every year. Women aged 55 years and older should switch to mammograms every 2 years, or have the choice to continue yearly screening. Screening with mammography and clinical breast exam annually. For women aged 50 to 69 years, screening with mammography is recommended. Women with an average risk of breast cancer – most women – should begin yearly mammograms at age 45. Women should be able to start the screening as early as age 40, if they want to. It's a good idea to start talking to your health care provider at age 40 about when you should begin screening.
A mammogram is an x-ray of the breast. While screening mammograms are routinely administered to detect breast cancer in women who have no apparent symptoms, diagnostic mammograms are used after suspicious results on a screening mammogram or after some signs of breast cancer alert the physician to check the tissue.
Once A Month
Adult women of all ages are encouraged to perform breast self-exams
at least once a month. “Forty percent of diagnosed breast cancers
are detected by women who feel a lump, so establishing a regular
breast self-exam is very important.” While mammograms can help you
to detect cancer before you can feel a lump, breast self-exams help
you to be familiar with how your breasts look and feel so you can
alert your healthcare professional if there are any changes.
Breast Self-Exam
1) In the Shower
Using the pads of your fingers, move around your entire breast in a
circular pattern moving from the outside to the center, checking
the entire breast and armpit area. Check both breasts each month
feeling for any lump, thickening, or hardened knot. Notice any
changes and get lumps evaluated by your healthcare provider.
2) In Front of a Mirror
Visually inspect your breasts with your arms at your sides. Next,
raise your arms high overhead. Look for any changes in the contour,
any swelling, or dimpling of the skin, or changes in the nipples.
Next, rest your palms on your hips and press firmly to flex your
chest muscles. Left and right breasts will not exactly match—few
women's breasts do, so look for any dimpling, puckering, or
changes, particularly on one side.
3) Lying Down
When lying down, the breast tissue spreads out evenly along the
chest wall. Place a pillow under your right shoulder and your right
arm behind your head. Using your left hand, move the pads of your
fingers around your right breast gently in small circular motions
covering the entire breast area and armpit. Use light, medium, and
firm pressure. Squeeze the nipple; check for discharge and lumps.
Repeat these steps for your left breast
Mammogram
A mammogram is an x-ray that allows a qualified specialist to
examine the breast tissue for any suspicious areas. The breast is
exposed to a small dose of ionizing radiation that produces an
image of the breast tissue. Mammograms can often show a breast lump
before it can be felt. They also can show tiny clusters of calcium
called microcalcifications. Lumps or specks can be caused by
cancer, fatty cells, or other conditions like cysts. Further tests
are needed to find out if abnormal cells are present. What Happens
If My Mammogram Results Are Abnormal? If the mammogram shows an
abnormal area of the breast, your doctor will order additional
tests offering clearer, more detailed images of that area. Although
lumps are usually non-cancerous, the only way to be certain is to
perform additional tests, such as an ultrasound or MRI. If further
tests show that the mass is solid, your radiologist may recommend a
biopsy, a procedure in which cells are removed from a suspicious
area to check for the presence of cancer.
Mammography
Mammography can detect tumors before they can be felt, so screening
is key for early detection. But when combined with regular medical
care and appropriate guideline-recommended mammography, breast
self-exams can help women know what is normal for them so they can
report any changes to their healthcare provider. If you find a
lump, schedule an appointment with your doctor, but don't panic — 8
out of 10 lumps are not cancerous. For additional peace of mind,
call your doctor whenever you have concerns.
Clinical Breast Exam
A clinical breast exam is performed by a healthcare professional
who is trained to recognize many different types of abnormalities
and warning signs. This in-office exam will most likely be
completed by your family physician or gynecologist at your annual
exam, whereas your breast self-exam is something every woman should
do at once at month at home. During a clinical breast exam, your
healthcare provider checks your breasts’ appearance. You may be
asked to raise your arms over your head, let them hang by your
sides, or press your hands against your hips. These postures allow
your healthcare provider to look for differences in size or shape
between your breasts. The skin covering your breasts is checked for
any rash, dimpling, or other abnormal signs. Your nipples may be
checked to see if fluid is expressed when lightly squeezed.
A Manual Check for Unusual Texture or Lumps
Using the pads of the fingers, your healthcare provider checks your entire breast, underarm, and collarbone area for any lumps or abnormalities. It is worth noting that some women have breast tissue that appears to be full of tiny fibrous bumps or ridges throughout the breast tissue, known as fibrocystic breasts. Overall lumpy tissue is something your provider will want to note but is unrelated to cancer.
A suspicious lump –the type your physician is checking for– is generally about the size of a pea before anyone can feel it in the breast tissue. The manual exam is done on one side and then the other. Your healthcare provider will also check the lymph nodes near the breast to see if they are enlarged.
An Assessment of Any Suspicious Area
If a lump is discovered, your healthcare provider will note its size, shape, and texture. He or she will also check to see if the lump moves easily. Benign lumps often feel different from cancerous ones, but any lump found will likely need to be examined with further diagnostic measures.
It may be helpful to know that lumps that appear soft, smooth, round, and movable are likely to be either benign tumors or cysts. A lump that is hard and oddly-shaped and feels firmly attached within the breast is more likely to be cancer, but further tests are needed to diagnose the problem.
The Value of Clinical Breast Exams
Clinical Breast exams are an important part of early detection. Although most lumps are discovered through breast self-exams, an experienced professional may notice a suspicious place that fails to register as a warning in the patient’s mind.
Make a case for breast cancer screening with mammography before age 50 from a perspective of...
A woman is worried that she might have breast cancer. The standard test for breast cancer is mammography. From research she found online, she discovers the sensitivity for the mammography screening is 83% and the specificity is 96% . Her doctor has told her that one in 45 women in her forties will have breast cancer. Based on the sensitivity, specificity, and prevalence, determine the positive predictive value (PPV) for the mammography screening. Express your answer to three decimal places.
A woman is worried that she might have breast cancer. The standard test for breast cancer is mammography. From research she found online, she discovers the sensitivity for the mammography screening is 89% and the specificity is 96%. Her doctor has told her that one in 61 women in her forties will have breast cancer. Based on the sensitivity, specificity, and prevalence, determine the positive predictive value (PPV) for the mammography screening. Express your answer to three decimal places. PPV...
The incidence of breast cancer varies depending on a woman's age. The National Cancer Institute gives the following probabilities for a randomly chosen woman in her 40s who takes a mammography to screen for breast cancer 0.8 Positive 0.2 Negative Postive 0.9 Negative Cancer 0.0149 0.9851 No cancer A true positive happens when someone getting a mammography has cancer and recelves a positive test result. What percent of women in their 40s taking a screening mammography receive a true positive?...
The Table below presents data related to a screening test for breast cancer. Questions 5 – 8 refer to the data in the Table. Screening Test for Breast Cancer Cancer Cancer Confirmed Cancer not Confirmed Total Positive 132 983 1115 Negative 45 63650 63695 Total 177 64633 64810 5. Using the data in the above table, present the formula and calculate the sensitivity of the screening test. 6. What is the specificity of the screening test (show the formula along...
A screening test for breast cancer is used in the same way in two similar populations, population A and population B. The positive predictive value for the screening test in population A is higher than the positive predictive value population B. What is the likely explanation of this discovery? (NOTE: The same test is used the same way in the two populations) (Choose the one best answer) The prevalence of disease is lower in population A than in population B....
***PLEASE label what answer is for what question as clear as possible**** (Yes this is ONE question) Suppose that 50,000 women who have never had a breast cancer diagnosis are available and willing to participate in a new screening program of computerized digital mammography. At the first screen, 1132 women were positive on the screening test. All of these positive women had a breast biopsy and 136 were diagnosed with breast cancer. Of the 48,868 who screened “negative” on the...
A psychiatrist devised a short screening test for depression. In order to determine this new test’s validity, an independent blind comparison was made with a gold standard for diagnosis of depression among a group of 200 psychiatric outpatients. Among the 50 outpatients found to be depressed according to the gold standard, 35 patients were positive for the test. Among 150 patients found not to be depressed according to the gold standard, 30 patients were found to be positive for the...
4. Breast cancer occurs most frequently among older women, Of all age groups, women in their 60s have the highest rate of breast cancer. It is estimated that 3.7% of women in their 60s get breast cancer. Mammograms are X-ray images of the breast used to detect breast cancer. A mammogram can typically identify correctly 84.9% of cancer cases (sensitivity 84.9%) and 95.13% of cases without cancer (specificity = 95%). (This is exactly like problem #11) First write down the...
Diabetes Screening Shown below are the real-life diagnostic characteristics of a particular diabetes-screening test – a fasting venous glucose measurement – from a hypothetical cross-sectional study population. Calculate the sensitivity, specificity and positive predictive value (PPV) of this screening test and estimate the prevalence of diabetes in the study population. Table: Results of fasting venous glucose screening for diabetes. Diabetes Screening Test Actual diabetes status Total Present Absent Positive (+) True + 67 False + 38 Total + 105 Negative...
A new screening test for colon cancer is developed. The screening test is evaluated by comparing results of 500 patient MRI results (in this case, considered the “gold standard” or confirming diagnostic tool). Of the 264 people who had a positive result on the new test, 211 were confirmed to have the disease by the MRI. Of the 236 people who had a negative result on the test, 97 were confirmed to have the disease by the MRI. Please calculate...